Norway Mesenchymal Stem Cells Market Size & Outlook
Norway mesenchymal stem cells market, 2018-2030 (US$M)
Related Markets
Norway mesenchymal stem cells market highlights
- The Norway mesenchymal stem cells market generated a revenue of USD 29.9 million in 2023 and is expected to reach USD 65.1 million by 2030.
- The Norway market is expected to grow at a CAGR of 11.8% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & services in 2023.
- Services is the most lucrative product & services segment registering the fastest growth during the forecast period.
Mesenchymal stem cells market data book summary
| Market revenue in 2023 | USD 29.9 million |
| Market revenue in 2030 | USD 65.1 million |
| Growth rate | 11.8% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, Merck KGaA, Lonza Group Ltd, PromoCell GmbH, Cyagen Biosciences, Stemedica Cell Technologies, Axol Bioscience, Celprogen, Cellcolabs, Visual Photonics Epitaxy |
Other key industry trends
- In terms of revenue, Norway accounted for 1.0% of the global mesenchymal stem cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany mesenchymal stem cells market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 325.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Mesenchymal Stem Cells Market Scope
Mesenchymal Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway mesenchymal stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mesenchymal stem cells market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 79.93% in 2023. Horizon Databook has segmented the Norway mesenchymal stem cells market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
The country’s commitment to stem cell research is well-recognized, with robust funding mechanisms and a supportive policy environment, propelling Norwegian scientists to the forefront of global stem cell research & application.
Furthermore, Norway has been actively funding stem cell research, with the Research Council of Norway (RCN) administering the Stem Cell Research Program, which is a priority area in the country. The program, launched in 2008, aims to develop & enhance expertise within basic and clinical research on stem cells to find treatments for seriously and chronically ill patients.
Reasons to subscribe to Norway mesenchymal stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway mesenchymal stem cells market databook
-
Our clientele includes a mix of mesenchymal stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway mesenchymal stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Norway mesenchymal stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway mesenchymal stem cells market size, by product & services, 2018-2030 (US$M)
Norway Mesenchymal Stem Cells Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
